Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis.
Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis.
复制标题
DOI：
10.1161/circulationaha.120.046464
复制
发表时间：
2021-09-21
期刊：
影响因子：
37.8
通讯作者：
Choudhury RP
中科院分区：
文献类型：
--
作者：
Edgar L;Akbar N;Braithwaite AT;Krausgruber T;Gallart-Ayala H;Bailey J;Corbin AL;Khoyratty TE;Chai JT;Alkhalil M;Rendeiro AF;Ziberna K;Arya R;Cahill TJ;Bock C;Laurencikiene J;Crabtree MJ;Lemieux ME;Riksen NP;Netea MG;Wheelock CE;Channon KM;Rydén M;Udalova IA;Carnicer R;Choudhury RP
文本中提供了补充数字内容。尽管进行了降糖治疗，糖尿病患者的心血管风险仍然很高。我们假设高血糖会诱导巨噬细胞训练有素的免疫力，促进持久的促动脉粥样硬化特征。来自对照小鼠和糖尿病小鼠的骨髓源性巨噬细胞在生理葡萄糖 (5 mmol/L) 中生长，并进行 RNA 测序 (n=6)、转座酶可及染色质测序 (n=6) 和染色质免疫沉淀测序 (n=6)，以确定高血糖诱导的训练免疫力。将患有（n = 9）或不患有（n = 6）糖尿病的小鼠的骨髓移植到（血糖正常）Ldlr -/− 小鼠中以评估其体内功能意义。与对照受试者（n=16）相比，在糖尿病患者（n=8）的人外周血单核细胞以及通过激光捕获显微切割切除的人动脉粥样硬化斑块巨噬细胞中寻找高血糖诱导的训练有素的免疫力的证据。在巨噬细胞中，高细胞外葡萄糖通过糖酵解依赖性机制促进促炎基因表达和促动脉粥样硬化功能特征。糖尿病小鼠的骨髓来源的巨噬细胞保留了这些特征，即使在生理葡萄糖中培养时也是如此，这表明高血糖诱导了训练有素的免疫力。将糖尿病小鼠的骨髓移植到（血糖正常）Ldlr -/− 小鼠中会增加主动脉根部动脉粥样硬化，证实了一种与疾病相关且持久的经过训练的先天免疫。对转座酶可及染色质、染色质免疫沉淀以及造血干细胞和骨髓源性巨噬细胞的 RNA 测序分析的综合分析揭示了糖尿病中的促炎启动效应。开放染色质的模式涉及转录因子 Runt 相关转录因子 1 (Runx1)。同样，2 型糖尿病患者的动脉粥样硬化斑块巨噬细胞和外周白细胞的转录组也富含 Runx1 靶标，这与人类疾病中的潜在作用一致。 Runx1 的体外药理学抑制抑制了训练的表型。高血糖诱导的训练有素的免疫力可能解释了为什么针对升高的血糖在降低糖尿病大血管风险方面无效，并为疾病预防和治疗提出了新的目标。
Supplemental Digital Content is available in the text. Cardiovascular risk in diabetes remains elevated despite glucose-lowering therapies. We hypothesized that hyperglycemia induces trained immunity in macrophages, promoting persistent proatherogenic characteristics. Bone marrow–derived macrophages from control mice and mice with diabetes were grown in physiological glucose (5 mmol/L) and subjected to RNA sequencing (n=6), assay for transposase accessible chromatin sequencing (n=6), and chromatin immunoprecipitation sequencing (n=6) for determination of hyperglycemia-induced trained immunity. Bone marrow transplantation from mice with (n=9) or without (n=6) diabetes into (normoglycemic) Ldlr −/− mice was used to assess its functional significance in vivo. Evidence of hyperglycemia-induced trained immunity was sought in human peripheral blood mononuclear cells from patients with diabetes (n=8) compared with control subjects (n=16) and in human atherosclerotic plaque macrophages excised by laser capture microdissection. In macrophages, high extracellular glucose promoted proinflammatory gene expression and proatherogenic functional characteristics through glycolysis-dependent mechanisms. Bone marrow–derived macrophages from diabetic mice retained these characteristics, even when cultured in physiological glucose, indicating hyperglycemia-induced trained immunity. Bone marrow transplantation from diabetic mice into (normoglycemic) Ldlr −/− mice increased aortic root atherosclerosis, confirming a disease-relevant and persistent form of trained innate immunity. Integrated assay for transposase accessible chromatin, chromatin immunoprecipitation, and RNA sequencing analyses of hematopoietic stem cells and bone marrow–derived macrophages revealed a proinflammatory priming effect in diabetes. The pattern of open chromatin implicated transcription factor Runt-related transcription factor 1 (Runx1). Similarly, transcriptomes of atherosclerotic plaque macrophages and peripheral leukocytes in patients with type 2 diabetes were enriched for Runx1 targets, consistent with a potential role in human disease. Pharmacological inhibition of Runx1 in vitro inhibited the trained phenotype. Hyperglycemia-induced trained immunity may explain why targeting elevated glucose is ineffective in reducing macrovascular risk in diabetes and suggests new targets for disease prevention and therapy.
影响因子：
6.9
作者：
Turner RJ;Bushnell CD;Register TC;Sharp FR
通讯作者：
Sharp FR